Methyl 5-(pyridin-2-yl)-1H-pyrazole-3-carboxylate, 95.0%, 250mg

Methyl 5-bromo-2-methoxy-4-methylbenzoate, 95.0%, 1g

3-((4-(tert-butyl)phenyl)sulfonamido)benzoic acid, 95.0%, 1g

Sample vials ROTILABO® with beaded rim, 20 ml, 200 Piece(s)

2-(2,4-Dioxo-1,3-diazinan-1-yl)acetic acid, 95%, 500mg

Bismuth subcarbonate, min. 97.5%, USP, 1 kg, plastic packaging.

EZATIOSTAT, 95%, 5mg

N,n-methylenebismethacrylamide, 96%, 1g

(S)-3-Amino-5-(methylthio)pentanoic acid, 97%, 250mg

2,2',2''-(1,4,7,10-Tetraazacyclododecane-1,4,7-triyl)triacetic acid, 97%, 1g

Benzofurazan-4-sulfonyl chloride, 95.0%, 5g

(1R,2R)-N,N,N',N'-Tetramethyl-1,2-cyclohexanediamine>95.0%(GC)(T)250mg

5-Nitro-2-pyridinecarboxylic acid, 95.0%, 1g